| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 1.1.2. Injectable medicines |
Others observations: Therapeutic alternatives: thiopental |
| Brazil (incomplete list) | A.1.2. Agentes intravenosos |
Others observations: Uso hospitalar, compreendendo emprego de medicamentos em pacientes internados ou em pacientes de ambulatório que necessitam de atendimento especializado ou ainda quando a administração implique risco à saúde. Fármaco sujeito a controle especial; Lista C1 (Portaria SVS 344/98). Uso restrito para procedimentos de curta duração |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Cuba | 1.1 Anestésicos generales | No observations |
| Training CSamouge 2022 | 1.1.2 Injectable medicines |
Others observations: Therapeutic alternatives: thiopental |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 1.1.2. Injectable medicines |
Others observations: Therapeutic alternatives: thiopental |
| Training CSamouge 2022 | 1.1.2 Injectable medicines |
Others observations: Therapeutic alternatives: thiopental |
| List | Section | Observation |
|---|---|---|
| Peru | 1.1 General Anesthetics and Oxygen | No observations |